COCRYSTAL PHARMA, INC. Common Stock, Capital Shares Reserved for Future Issuance
COCRYSTAL PHARMA, INC. (COCP) had Common Stock, Capital Shares Reserved for Future Issuance of 10.17 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 10.17M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 10.18M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 9.49M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 833.00K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 10.17M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 10.18M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 9.49M shares 10-K · filed 2026-03-31 | |
| 2024-12-31 | 833.00K shares 10-K · filed 2026-03-31 | |
| 2024-09-30 | 22.00K shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 833.00K shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 833.00K shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 844.00K shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 846.00K shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 847.00K shares 10-Q · filed 2024-08-14 | |
| 2023-03-31 | 847.00K shares 10-Q · filed 2024-05-13 | |
| 2022-12-31 | 854.00K shares 10-K · filed 2024-03-28 | |
| 2022-09-30 | 854.00K shares 10-Q · filed 2023-11-13 | |
| 2022-06-30 | 10.25M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 855.00K shares 10-Q · filed 2023-05-15 | 10.25M shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 854.00K shares 10-K · filed 2023-03-29 | 10.26M shares 10-K · filed 2022-03-23 |
| 2021-09-30 | 855.00K shares 10-Q · filed 2022-11-14 | 10.26K shares 10-Q · filed 2021-11-15 |
| 2021-06-30 | 10.26M shares 10-Q · filed 2022-08-15 | 1.68M shares 10-Q · filed 2021-08-16 |
| 2021-03-31 | 4.28M shares 10-Q · filed 2022-05-11 | |
| 2020-12-31 | 4.29M shares 10-K · filed 2022-03-23 | |
| 2020-09-30 | 4.76K shares 10-Q · filed 2021-11-15 | 4.76M shares 10-Q · filed 2020-11-13 |
| 2020-06-30 | 2.04M shares 10-Q · filed 2021-08-16 | 4.76M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 4.76M shares 10-Q · filed 2021-05-17 | |
| 2019-12-31 | 4.76M shares 10-K · filed 2021-03-17 | |
| 2019-09-30 | 4.76M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 4.76M shares 10-Q · filed 2020-11-13 | |
| 2019-03-31 | 2.47M shares 10-Q · filed 2020-05-13 | |
| 2018-12-31 | 2.47M shares 10-K · filed 2020-03-27 | |
| 2018-09-30 | 2.48M shares 10-Q · filed 2019-11-12 | |
| 2018-06-30 | 2.48M shares 10-Q · filed 2019-08-09 | |
| 2018-03-31 | 2.69M shares 10-Q · filed 2019-05-10 | |
| 2017-12-31 | 2.70M shares 10-K · filed 2019-04-01 | |
| 2017-09-30 | 77.29M shares 10-Q · filed 2017-11-08 | |
| 2017-06-30 | 78.99M shares 10-Q · filed 2017-08-08 | |
| 2017-03-31 | 78.99M shares 10-Q · filed 2017-05-10 | |
| 2016-12-31 | 2.63M shares 10-K · filed 2018-03-21 | 78.99M shares 10-K · filed 2017-03-31 |
| 2016-09-30 | 78.71M shares 10-Q · filed 2016-11-09 | |
| 2016-06-30 | 78.71M shares 10-Q · filed 2016-08-09 | |
| 2015-12-31 | 80.84M shares 10-K · filed 2017-03-31 | 80.84K shares 10-K · filed 2016-03-15 |
| 2015-09-30 | 110.68K shares 10-Q · filed 2015-11-16 | |
| 2015-06-30 | 110.68K shares 10-Q · filed 2015-08-14 | |
| 2015-03-31 | 12.63K shares 10-Q · filed 2015-05-14 | |
| 2014-12-31 | 79.19K shares 10-K · filed 2016-03-15 | 79.09M shares 10-K · filed 2015-03-31 |
| 2014-09-30 | 53.60M shares 10-Q · filed 2014-11-14 | |
| 2014-06-30 | 53.60M shares 10-Q · filed 2014-08-14 | |
| 2014-03-31 | 53.60M shares 10-Q · filed 2014-05-15 | |
| 2013-12-31 | 154.55M shares 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |